COPYRIGHT © 2023 Blest-Hopley, Amit, O’Neill and Ru ell. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or… Click to show full abstract
COPYRIGHT © 2023 Blest-Hopley, Amit, O’Neill and Ru ell. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders
               
Click one of the above tabs to view related content.